[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]
IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII | |
1990 | 0 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | |||||
1991 | 0 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | |||||
1992 | 0 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | |||||
1993 | 0 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | |||||
1994 | 0 | 0.11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | |||||
1995 | 0 | 0.19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | |||||
1996 | 0 | 0.22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | |||||
1997 | 0 | 0.22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.09 | |||||
1998 | 0 | 0.26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.12 | |||||
1999 | 0 | 0.28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.14 | |||||
2000 | 0 | 0.33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.15 | |||||
2001 | 0 | 0.36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.15 | |||||
2002 | 0 | 0.39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.21 | |||||
2003 | 0 | 0.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | |||||
2004 | 0 | 0.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | |||||
2005 | 0 | 0.46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.22 | |||||
2006 | 0 | 0.46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.21 | |||||
2007 | 0 | 0.42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.18 | |||||
2008 | 0 | 0.44 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.21 | |||||
2009 | 0 | 0.44 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.21 | |||||
2010 | 0 | 0.43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.18 | |||||
2011 | 0 | 0.46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.21 | |||||
2012 | 0 | 0.47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.19 | |||||
2013 | 0 | 0.53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.22 | |||||
2014 | 0 | 0.55 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.22 | |||||
2015 | 0 | 0.56 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.21 | |||||
2016 | 0 | 0.58 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | |||||
2017 | 0 | 0.6 | 0.06 | 0 | 31 | 31 | 5 | 2 | 2 | 0 | 0 | 1 | 50 | 2 | 0.06 | 0.22 | ||
2018 | 0.06 | 0.76 | 0.05 | 0.06 | 43 | 74 | 3 | 4 | 6 | 31 | 2 | 31 | 2 | 1 | 25 | 2 | 0.05 | 0.31 |
IF: | Impact Factor: C2Y / D2Y |
AIF: | Average Impact Factor for series in RePEc in year y |
CIF: | Cumulative impact factor |
IF5: | Impact Factor: C5Y / D5Y |
DOC: | Number of documents published in year y |
CDO: | Cumulative number of documents published until year y |
CIT: | Number of citations to papers published in year y |
NCI: | Number of citations in year y |
CCU: | Cumulative number of citations to papers published until year y |
D2Y: | Number of articles published in y-1 plus y-2 |
C2Y: | Cites in y to articles published in y-1 plus y-2 |
D5Y: | Number of articles published in y-1 until y-5 |
C5Y: | Cites in y to articles published in y-1 until y-5 |
SC: | selft citations in y to articles published in y-1 plus y-2 |
%SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
CiY: | Cites in year y to documents published in year y |
II: | Immediacy Index: CiY / Documents. |
AII: | Average Immediacy Index for series in RePEc in year y |
# | Year | Title | Cited |
---|---|---|---|
1 | 2017 | Can Price Transparency Contribute to More Affordable Patient Access to Medicines?. (2017). Vogler, Sabine ; Paterson, Kenneth R. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0028-1. Full description at Econpapers || Download paper | 2 |
2 | 2018 | The Impact of Brexit on Pharmaceuticals and HTA. (2018). Lorgelly, Paula. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-018-0072-5. Full description at Econpapers || Download paper | 1 |
3 | 2017 | Model Registration: A Call to Action. (2017). Sampson, Christopher ; Wrightson, Tim . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:2:d:10.1007_s41669-017-0019-2. Full description at Econpapers || Download paper | 1 |
4 | 2018 | Application of Discrete-Choice Experiment Methods in Tobacco Control: A Systematic Review. (2018). Regmi, Kabindra ; Afiqah, Nik Annie ; Timilsina, Sabina ; Kaphle, Dinesh. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:1:d:10.1007_s41669-017-0025-4. Full description at Econpapers || Download paper | 1 |
5 | 2017 | Comment on: âForecasting Pharmaceutical Prices for Economic Evaluations When There is No Market: A Reviewâ. (2017). Holko, Przemysaw . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:1:d:10.1007_s41669-016-0008-x. Full description at Econpapers || Download paper | 1 |
6 | 2017 | Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values. (2017). Round, Jeff ; Hawton, Annie. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:4:d:10.1007_s41669-017-0027-2. Full description at Econpapers || Download paper | 1 |
7 | 2018 | Including Future Consumption and Production in Economic Evaluation of Interventions that Save Life-Years: Commentary. (2018). Nord, Erik ; Lamoy, Christoffer. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:4:d:10.1007_s41669-018-0079-y. Full description at Econpapers || Download paper | 1 |
8 | 2018 | Hospital Pharmacists in Europe: Between Warehouse and Prescription Pad?. (2018). Garattini, Livio ; Padula, Anna. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:3:d:10.1007_s41669-018-0069-0. Full description at Econpapers || Download paper | 1 |
9 | 2017 | Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review. (2017). Kolovos, Spyros ; Tulder, Maurits W ; Chevreul, Karine ; Riper, Heleen ; Bosmans, Judith E. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0014-7. Full description at Econpapers || Download paper | 1 |
# | Year | Title | Cited |
---|---|---|---|
1 | 2017 | Can Price Transparency Contribute to More Affordable Patient Access to Medicines?. (2017). Vogler, Sabine ; Paterson, Kenneth R. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0028-1. Full description at Econpapers || Download paper | 2 |
Year | Title | |
---|---|---|
2018 | Cost-Effectiveness Analysis of Crohnâs Disease Treatment with Vedolizumab and Ustekinumab After Failure of Tumor Necrosis Factor-α Antagonist. (2018). Holko, Przemysaw ; Pilc, Andrzej ; Kawalec, Pawe. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0653-2. Full description at Econpapers || Download paper | |
2018 | Direct Mapping of the QLQ-C30 to EQ-5D Preferences: A Comparison of Regression Methods. (2018). Crott, Ralph . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-017-0049-9. Full description at Econpapers || Download paper |
Year | Citing document | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
2018 | Delving into the Impact of Job Match and Remuneration on Burnout and Turnover Intention among Pharmacists in Pakistan. (2018). Matloob, Sheema ; Sikander, Raja ; Halim, Hasliza Abdul ; Bhatti, Zohra. In: International Journal of Academic Research in Business and Social Sciences. RePEc:hur:ijarbs:v:8:y:2018:i:6:p:898-911. Full description at Econpapers || Download paper | |||||||||
2018 | EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties. (2018). Kaltenthaler, Eva ; Dickson, Rumona ; Buyukkaramikli, Nasuh ; Joore, Manuela ; Ramaekers, Bram ; Brazzelli, Miriam ; Grimm, Sabine ; Armoiry, Xavier ; Riemsma, Rob ; Shepherd, Jonathan ; Hodgson, Robert ; Hoyle, Martin ; Woolacott, Nerys ; Edwards, Steve ; Kotas, Eleanor ; Pandor, Abdullah ; Duarte, Rui ; Stevenson, Matt ; Boland, Angela. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:16:y:2018:i:4:d:10.1007_s40258-018-0393-7. Full description at Econpapers || Download
10 most frequent citing series
|